INOVIO PHARMACEUTICALS, INC. Shareholders' Equity
INOVIO PHARMACEUTICALS, INC. (INO) had Shareholders' Equity of $4.37 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $4.37M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $6.07M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $24.10M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$7.72M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $4.37M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $6.07M 10-Q · filed 2026-08-12 |
| 2025-12-31 | $24.10M 10-Q · filed 2026-08-12 |
| 2025-09-30 | -$7.72M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $28.53M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $51.25M 10-Q · filed 2026-08-12 |
| 2024-12-31 | $68.50M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $73.54M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $96.74M 10-Q · filed 2025-11-10 |
| 2024-03-31 | $94.44M 10-Q · filed 2025-11-10 |
| 2023-12-31 | $117.35M 10-K · filed 2026-03-12 |
| 2023-09-30 | $138.16M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $169.37M 10-Q · filed 2024-11-14 |
| 2023-03-31 | $199.21M 10-Q · filed 2024-11-14 |
| 2022-12-31 | $222.36M 10-K · filed 2025-03-18 |
| 2022-09-30 | $266.70M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $297.67M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $355.09M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $399.67M 10-K · filed 2024-03-06 |
| 2021-09-30 | $453.57M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $508.55M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $581.61M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $461.14M 10-K · filed 2024-03-06 |
| 2020-09-30 | $323.90M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $186.26M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $184.32M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.44M 10-K · filed 2021-03-01 |
| 2019-09-30 | $33.69M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $53.62M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $77.91M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $86.94M 10-K · filed 2020-03-12 |
| 2018-09-30 | $103.61M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $111.40M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $113.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $142.39M 10-K · filed 2019-03-12 |
| 2017-09-30 | $162.02M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $123.43M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $105.85M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $123.28M 10-K · filed 2018-03-14 |
| 2016-09-30 | $146.88M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $161.99M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $170.97M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $175.69M 10-K · filed 2017-03-15 |
| 2015-09-30 | $193.14M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $180.56M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $103.12M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $111.23M 10-K · filed 2016-03-14 |
| 2014-09-30 | $116.73M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $121.84M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $128.74M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $52.46M 10-K · filed 2015-03-16 |
| 2013-09-30 | $61.76M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $29.20M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $39.93M 10-Q · filed 2013-05-10 |
| 2012-12-31 | $34.35M 10-K · filed 2014-03-17 |
| 2012-09-30 | $30.76M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $35.83M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $39.69M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $47.31M 10-K · filed 2013-03-18 |
| 2011-09-30 | $50.75M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $55.01M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $46.50M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |